BLAC
Bellevue Life Sciences Acquisition Corp.
1W: -73.2%
1M: -73.5%
3M: -72.8%
1Y: -71.2%
$3.01
Last traded 2025-02-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$7.0M
52W Range3.01-13.4
Volume430,774
Avg Volume15,258
Beta0.53
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKuk Hyoun Hwang
SectorFinancial Services
IndustryShell Companies
IPO Date2023-03-21
Websitebellevuespac.com
10900 NE 4th Street
Bellevue, WA 98004
US
Bellevue, WA 98004
US
425 635 7700
About Bellevue Life Sciences Acquisition Corp.
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kim Sang Hyun | 0 | — | 2024-06-23 | |
| Lee Phil Geon | 0 | — | 2024-05-27 | |
| Hwang Kuk Hyoun | J-Other | 20,000 | — | 2023-03-23 |
| Hwang Kuk Hyoun | J-Other | 20,000 | $11.50 | 2023-03-23 |
| Yoo David Jin | A-Award | 20,000 | — | 2023-03-23 |